Amgen 2011 Annual Report Download - page 115

Download and view the complete annual report

Please find page 115 of the 2011 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 184

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184

Exhibit No. Description
4.23 Officers’ Certificate of Amgen Inc., dated as of June 30, 2011, including forms of the Company’s
2.30% Senior Notes due 2016, 4.10% Senior Notes due 2021 and 5.65% Senior Notes due 2042.
(Filed as an exhibit to Form 8-K on June 30, 2011 and incorporated herein by reference.)
4.24 Officers’ Certificate of Amgen Inc., dated as of November 10, 2011, including forms of the
Company’s 1.875% Senior Notes due 2014, 2.50% Senior Notes due 2016, 3.875% Senior Notes
due 2021 and 5.15% Senior Notes due 2041. (Filed as an exhibit to Form 8-K on November 10,
2011 and incorporated herein by reference.)
4.25 Officers’ Certificate of Amgen Inc., dated as of December 5, 2011, including forms of the
Company’s 4.375% Senior Notes due 2018 and 5.50% Senior Notes due 2026. (Filed as an exhibit
to Form 8-K on December 5, 2011 and incorporated herein by reference.)
10.1+ Amgen Inc. 2009 Equity Incentive Plan. (Filed as Appendix A to Amgen Inc.’s Proxy Statement
on March 26, 2009 and incorporated herein by reference.)
10.2+ Form of Stock Option Agreement for the Amgen Inc. 2009 Equity Incentive Plan. (As Amended
on March 2, 2011.) (Filed as an exhibit to Form 10-Q for the quarter ended March 31, 2011 on
May 10, 2011 and incorporated herein by reference.)
10.3+ Form of Restricted Stock Unit Agreement for the Amgen Inc. 2009 Equity Incentive Plan. (As
Amended on March 2, 2011.) (Filed as an exhibit to Form 10-Q for the quarter ended March 31,
2011 on May 10, 2011 and incorporated herein by reference.)
10.4+ Amgen Inc. 2009 Performance Award Program. (As Amended and Restated on December 4,
2009.) (Filed as an exhibit to Form 10-K for the year ended December 31, 2009 on March 1, 2010
and incorporated herein by reference.)
10.5+ Form of Performance Unit Agreement for the Amgen Inc. 2009 Performance Award Program. (As
Amended on March 2, 2011.) (Filed as an exhibit to Form 10-Q for the quarter ended March 31,
2011 on May 10, 2011 and incorporated herein by reference.)
10.6+ Amgen Inc. 2009 Director Equity Incentive Program. (Filed as an exhibit to Form 8-K on May 8,
2009 and incorporated herein by reference.)
10.7+ Form of Grant of Non-Qualified Stock Option Agreement and Restricted Stock Unit Agreement
for the Amgen Inc. 2009 Director Equity Incentive Program. (Filed as an exhibit to Form 8-K on
May 8, 2009 and incorporated herein by reference.)
10.8+ Amgen Supplemental Retirement Plan. (As Amended and Restated effective January 1, 2009.)
(Filed as an exhibit to Form 10-Q for the quarter ended September 30, 2008 on November 7, 2008
and incorporated herein by reference.)
10.9+ First Amendment to the Amgen Supplemental Retirement Plan, effective April 11, 2011. (Filed as
an exhibit to Form 10-Q for the quarter ended June 30, 2011 on August 8, 2011 and incorporated
herein by reference.)
10.10+* Second Amendment to the Amgen Supplemental Retirement Plan, effective October 12, 2011.
10.11+* Third Amendment to the Amgen Supplemental Retirement Plan, executed December 16, 2011.
10.12+ Amended and Restated Amgen Change of Control Severance Plan. (As Amended and Restated
effective December 9, 2010 and subsequently amended effective March 2, 2011.) (Filed as an
exhibit to Form 10-Q for the quarter ended March 31, 2011 on May 10, 2011 and incorporated
herein by reference.)
10.13+ Amgen Inc. Executive Incentive Plan. (As Amended and Restated effective January 1, 2009.)
(Filed as an exhibit to Form 10-Q for the quarter ended September 30, 2008 on November 7, 2008
and incorporated herein by reference.)
10.14+ Amgen Inc. Executive Nonqualified Retirement Plan. (As Amended and Restated effective
January 1, 2009.) (Filed as an exhibit to Form 10-Q for the quarter ended September 30, 2008 on
November 7, 2008 and incorporated herein by reference.)
99